Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes
暂无分享,去创建一个
Nathaniel Osgood | Hyun J Lim | Xu Zhang | N. Osgood | Roland Dyck | R. Dyck | H. Lim | Xu Zhang
[1] S. Satchell,et al. Diabetic nephropathy. , 2012, Clinical medicine.
[2] D. Kleinbaum,et al. Survival Analysis: A Self-Learning Text. , 1996 .
[3] Martin Schumacher,et al. Misspecified regression model for the subdistribution hazard of a competing risk by Latouche A, Boisson V, Chevret S and Porcher R. Statistics in Medicine 2006; DOI: 10.2002/sim.2600 , 2007, Statistics in medicine.
[4] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[5] B. Stengel,et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). , 2005, Kidney international.
[6] S. Cole,et al. Competing risk regression models for epidemiologic data. , 2009, American journal of epidemiology.
[7] Melania Pintilie,et al. Analysing and interpreting competing risk data , 2007, Statistics in medicine.
[8] D. Cox. Regression Models and Life-Tables , 1972 .
[9] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[10] Joseph Cavanaugh,et al. Probability and Random Variables , 1999, Mathematical Modelling.
[11] R. DeFronzo. Diabetic nephropathy: Etiologic and therapeutic considerations , 1995 .
[12] D. Lin,et al. Non-parametric inference for cumulative incidence functions in competing risks studies. , 1997, Statistics in medicine.
[13] Mei-Jie Zhang,et al. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models , 2011, Comput. Methods Programs Biomed..
[14] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[15] Nathaniel Osgood,et al. Epidemiology of diabetes mellitus among First Nations and non-First Nations adults , 2010, Canadian Medical Association Journal.
[16] R. Light,et al. Competing Risk Factor Analysis of End-Stage Renal Disease and Mortality in Chronic Kidney Disease , 2008, American Journal of Nephrology.
[17] H. Bilo,et al. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1) , 2002, European Journal of Epidemiology.
[18] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[19] M Lunn,et al. Applying Cox regression to competing risks. , 1995, Biometrics.
[20] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[21] M. Harris,et al. Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993 , 1998, Diabetes Care.
[22] R. DeFronzo,et al. The natural history of diabetic nephropathy. , 1990, Seminars in nephrology.
[23] E. Friedman. Natural History of Diabetic Nephropathy , 1986 .
[24] John P Klein,et al. Modelling competing risks in cancer studies , 2006, Statistics in medicine.
[25] Mei-Jie Zhang,et al. Summarizing differences in cumulative incidence functions , 2008, Statistics in medicine.
[26] J. Satagopan,et al. A note on competing risks in survival data analysis , 2004, British Journal of Cancer.
[27] K. Bloch,et al. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. , 2004, Diabetes care.
[28] W. D. Ray. 4. Modelling Survival Data in Medical Research , 1995 .
[29] Jeffrey J. Gaynor,et al. On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data , 1993 .
[30] J. Nagy,et al. Prevention and treatment of diabetic nephropathy. , 2005, Diabetes research and clinical practice.
[31] Martin Schumacher,et al. A competing risks analysis of bloodstream infection after stem‐cell transplantation using subdistribution hazards and cause‐specific hazards , 2007, Statistics in medicine.
[32] Martin Schumacher,et al. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified , 2010, Statistics in medicine.
[33] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[34] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[35] M S Pepe,et al. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.
[36] J. Mau,et al. On a Graphical Method for the Detection of Time‐Dependent Effects of Covariates in Survival Data , 1986 .
[37] William A Ghali,et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. , 2006, Journal of clinical epidemiology.
[38] V. Sørensen,et al. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark , 2007, Diabetologia.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[40] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[41] J. Fine,et al. Parametric regression on cumulative incidence function. , 2007, Biostatistics.
[42] Walter R. Young,et al. The Statistical Analysis of Failure Time Data , 1981 .
[43] W. J. Johnson,et al. Survival rates of 2,728 patients with end-stage renal disease. , 1984, Mayo Clinic proceedings.
[44] D Machin,et al. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches , 2001, Statistics in medicine.
[45] R. Écochard,et al. The Impact of Type 2 Diabetes on Mortality in End-Stage Renal Disease Patients Differs between Genders , 2009, Nephron Clinical Practice.
[46] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[47] E. Scott. Modelling Survival Data in Medical Research , 1995 .
[48] T. Craven,et al. Racial differences in the incidence of end-stage renal disease. , 1996, Ethnicity & health.
[49] C. Abrass. Kidney Disease in Diabetes , 2004 .